BriaCell adds NYU cancer center to phase 3 breast cancer trial
Tweet Send to a Friend
BriaCell Therapeutics Corp. (NASDAQ: BCTX) (TSX: BCT) announced the addition of NYU Langone Health's Perlmutter Cancer Center as a clinical ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


